Related Experiment Video
Updated: Feb 18, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion
Adelaide Ij Young1, Paul Timpson1,2, David Gallego-Ortega1,2
1a Cancer Research Division , Garvan Institute of Medical Research and the Kinghorn Cancer Centre , 384 Victoria Street, Darlinghurst , NSW , Australia.
Abstract:
Myeloid cell leukemia-1 (MCL-1), closely related to B-cell lymphoma 2 (BCL-2), has a well-established role in cell survival and has emerged as an important target for cancer therapeutics. We have demonstrated that inhibiting MCL-1 is efficacious in suppressing tumour progression in pre-clinical models of breast cancer and revealed that in addition to its role in cell survival, MCL-1 modulated cellular invasion. Utilizing a MCL-1-specific genetic antagonist, we found two possible mechanisms; firstly MCL-1 directly binds to and alters the phosphorylation of the cytoskeletal remodeling protein, Cofilin, a protein important for cytoskeletal remodeling during invasion, and secondly MCL-1 modulates the levels SRC family kinases (SFKs) and their targets. These data provide evidence that MCL-1 activities are not limited to endpoints of extracellular and intracellular signaling culminating in cell survival as previously thought, but can directly modulate the output of SRC family kinases signaling during cellular invasion. Here we review the pleotropic roles of MCL-1 and discuss the implications of this newly discovered effect on protein kinase signaling for the development of cancer therapeutics.
Insights
Myeloid cell leukemia-1 (MCL-1) protein regulates cancer cell survival and invasion. Inhibiting MCL-1 suppressed breast cancer progression by affecting cytoskeletal remodeling and protein kinase signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Myeloid cell leukemia-1 (MCL-1) is a key regulator of cell survival, closely related to BCL-2.
- MCL-1 is an emerging therapeutic target for various cancers, including breast cancer.
Purpose of the Study:
- To investigate the role of MCL-1 in breast cancer progression beyond cell survival.
- To elucidate the mechanisms by which MCL-1 modulates cellular invasion.
Main Methods:
- Utilized a MCL-1-specific genetic antagonist in pre-clinical breast cancer models.
- Analyzed MCL-1's direct binding and phosphorylation effects on Cofilin.
- Assessed the impact of MCL-1 on SRC family kinases (SFKs) and their downstream targets.
Main Results:
- Inhibition of MCL-1 effectively suppressed tumor progression in breast cancer models.
- MCL-1 directly interacts with and alters Cofilin phosphorylation, impacting cytoskeletal remodeling during invasion.
- MCL-1 modulates SRC family kinases (SFKs) signaling pathways involved in cellular invasion.
Conclusions:
- MCL-1's functions extend beyond cell survival to directly influence protein kinase signaling during cancer cell invasion.
- Targeting MCL-1 offers a promising therapeutic strategy for breast cancer by impacting both survival and invasion mechanisms.
Related Concept Videos
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...
Abnormal Proliferation

